Despite a prevalence of over 50% among patients with systemic lupus erythematosus (SLE), neuropsychiatric symptoms of SLE (NP-SLE), including anxiety and movement disorders, have not been well understood. The paucity of data examining underlying mechanisms is what spurred the work of Carla M. Cuda, PhD, pointing to microglia as a driver of disease.
18 янв 2023
